Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

US11420929B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11420929-B2
Application numberUS-202117196873-A
CountryUS
Kind codeB2
Filing dateMar 9, 2021
Priority dateDec 22, 2005
Publication dateAug 23, 2022
Grant dateAug 23, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Phenoxy acetic acids and phenyl propionic acids and their use in improving mitochondrial energy output in a subject are provided herein. The present compounds are activators of PPARδ and may be useful for treating conditions mediated by the same.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of a compound of the following formula: or a pharmaceutically acceptable salt thereof, comprising saponification of a compound of formula (I): or a salt thereof, wherein: is a double bond, with either E or Z substitution; X 1 is C 1-6 alkyl substituted with morpholino; X 2 is phenylene; X 3 is phenyl substituted with one or more halogens; Ar is phenylene optionally substituted with methyl; Y 1 is O; Y 2 is O; Z is CH 2 ; R 1 is hydrogen; and R 2 is C 1-6 alkyl. 2. The process of claim 1 , wherein X 1 is morpholin-4-ylmethyl. 3. The process of claim 2 , wherein R 2 is methyl or ethyl. 4. The process of claim 1 , wherein the compound of formula (I) is methyl (Z)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl) propynyl]phenyl]allyloxy]-2-methylphenoxy]acetate, or a salt thereof. 5. The process of claim 1 , wherein the compound of formula (I) is methyl (E)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl) propynyl]phenyl]allyloxy]-2-methylphenoxy]acetate, or a salt thereof.

Assignees

Inventors

Classifications

  • not condensed and containing further heterocyclic rings, e.g. timolol · CPC title

  • having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid  {(cannabinoids A61K31/658)} · CPC title

  • C07C69/736Primary

    the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring · CPC title

  • not condensed and containing further heterocyclic rings, e.g. cromakalim · CPC title

  • having five-membered rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11420929B2 cover?
Phenoxy acetic acids and phenyl propionic acids and their use in improving mitochondrial energy output in a subject are provided herein. The present compounds are activators of PPARδ and may be useful for treating conditions mediated by the same.
Who is the assignee on this patent?
Vtv Therapeutics Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/5377. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).